L&T and Piramal Pharma Q2 results lift shares as margin falls and profit returns
Last Updated: 28th October 2026 - 02:25 pm
On 28 October 2026, Larsen and Toubro shares rose 5% after its Q2 consolidated profit increased 33% to ₹5,202 crore, while Piramal Pharma shares rose 12% as its consolidated profit turned positive at ₹5.58 crore. L&T reported higher revenue and order inflow, but its EBITDA margin declined. Piramal Pharma's revenue also increased during the quarter.
L&T reports ₹1.47 lakh crore order inflow as margin falls to 8.7%
L&T’s consolidated profit has climbed to ₹5,202 crore in the quarter under review from ₹3,926 crore in the corresponding quarter last year. In terms of revenue, L&T reported ₹78,750 crore in the quarter, a rise of 16% as per a company statement.
L&T also disclosed an increase in order inflow during the quarter. Its EBITDA margin was below the earlier 10% level, the company reported.
Piramal Pharma returns to profit at ₹5.58 crore
Piramal Pharma’s consolidated numbers have moved from a loss of ₹99.2 crore in the year ago quarter to a profit in the current quarter. Revenues have gone up by 28% to ₹2,617.1 crore in the quarter under review.
L&T shares rise 5% at 9:46 AM IST
Stock-market data recorded the L&T share move at 9:46 AM IST on 28 October 2026.
Piramal Pharma shares rise 12% at 9:46 AM IST
Stock-market data recorded the Piramal Pharma share move at 9:46 AM IST on 28 October 2026.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.
Aticles to read next
Titan share price closes at ₹4,337.90, slips 0.6% on October 28
UltraTech Cement share price closes at ₹11,104, down 0.4% on October 28
5paisa Capital Ltd